Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Feature
Nature Biotechnology 25, 403–417 (1 April 2007) | doi:10.1038/nbt0407-403
India's health biotech sector at a crossroads
&
Abstract
Indian biotech is at a crossroads. It must not only address the significant health needs of its domestic population, but also position itself to take advantage of the often more profitable global marketplace.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
